Subscribe to RSS
DOI: 10.1055/s-0038-1654120
Isolation and Purification of Highly Enriched Tissue Plasminogen Activator from Pig Heart[*]
Publication History
Publication Date:
27 June 2018 (online)
Summary
A method for the isolation of highly purified plasminogen activator from porcine heart was developed. Fresh, frozen tissue was homogenized and extracted with 5 M urea. Upon dilution of the urea extract with 0.02 M acetate buffer, 0.05 M NaCl, pH 5.0, a large amount of inert protein precipitated. It was removed by low-speed centrifugation, leaving an active, cell-free supernatant. CM Sephadex C-50, added to this solution, adsorbed the active material quantitatively. Washing of the ion exchanger with 0.02 M acetate buffer, 0.26 M NaCl, pH 5.0, removed additional impurities. The activator was eluted by increasing the NaCl concentration of the acetate buffer to 0.6 M. Further purification was achieved by a fractionated precipitation with ammonium sulfate at 30% saturation, pH 7.5. The precipitated activator was solubilized in 0.02 M acetate buffer, 0.6 M NaCl, pH 5.0. The resulting active solution was subjected to gel filtration in a column of Sephadex G-200, in the same buffer medium. In this step, a substantial amount of inert, higher molecular weight material was eliminated. The active fractions were pooled and diluted with 0.02 M acetate buffer, pH 5.5, to reduce the NaCl concentration to 0.15 M. This solution was passed through a column of SE Sephadex C-50, in 0.02 M acetate buffer, 0.15 M NaCl, pH 5.5, which adsorbed the active material. The activator was eluted from the column with a salt gradient (0.15 M to 0.4 M NaCl) in 0.02M acetate buffer,pH 5.5. From 3kg of heart tissue, about 1.5 mg of highly purified activator were obtained, in a yield of 35% (with respect to the urea extract). The preparation had a specific activity of 38,900 CTA units per mg protein, determined with a fluorometric assay method, using fluorescence labeled fibrin substrate and a calibration curve with a urokinase standard for conversion of the activity to CTA units. The product was highly stable, and it was devoid of unspecific protease activity. Disc electrophoresis in Polyacrylamide gel at pH 9.5 showed a single sharp band.
*) This work is part of the Ph.D. thesis of Hans Zaugg, submitted to the University of Berne.
**) Present address: Fa. Hoffmann-La Roche & Co. AC, Basel, Switzerland.
-
References
- 1 Albrechtsen O. K. The fibrinolytic activity of human tissues. Brit. J. Haemat 3: 284 1957;
- 2 Albrechtsen O. K. Fibrinolytic activity of animal tissues. Acta physiol. scand 39: 284 1957;
- 3 Alkjaersig N, Fletcher A. P, Sherry S. Epsilon-aminocaproic acid: an inhibitor of plasminogen activation. J. biol. Chem 234: 832 1959;
- 4 Astrup T, Permin P. M. Fibrinolysin in the animal organism. Nature (Lond.) 159: 681 1947;
- 5 Astrup T, Stage A. Isolation of a soluble fibrinolytic activator from animal tissue. Nature (Lond.) 170: 929 1952;
- 6 Astrup T, Albrechtsen O. K. Estimation of the plasminogen activator and the trypsin inhibitor in animal and human tissues. Scand. J. clin. Lab. Invest 9: 233 1957;
- 7 Astrup T, Müllertz S. The fibrin plate method for estimating fibrinolytic activity. Arch. Biochem 40: 346 1952;
- 8 Bachmann F, Fletcher A. P, Sherry S. Partial purification of plasminogen activator from pig heart. Fed. Proc 21: 64 1962; Abstr
- 9 Bachmann F, Fletcher A. P, Alkjaersig N, Sherry S. Partial purification and properties of the plasminogen activator from pig heart. Biochemistry 3: 1578 1964;
- 10 Blombäck B, Blombäck M. Purification of human and bovine fibrinogen. Arkiv f. Kemi 10: 424 1956;
- 11 Caviezel O. Untersuchungen über die quantitative Bestimmung des menschlichen Plasmins und seiner Hemmstoffe in vitro. Schweiz, med. Wschr 94: 555 1964;
- 12 Davis M. C, Englert M. E, de Benzo E. C. Interaction of streptokinase and human plasminogen. I. Combining of streptokinase and plasminogen observed in the ultracentrifuge under a variety of experimental conditions. J. biol. Chem 239: 2651 1964;
- 13 Fleisher M. S, Loeb L. On tissue fibrinolysin. J. biol. Chem 21: 477 1915;
- 14 Kok P, Astrup T. Isolation and purification of a tissue plasminogen activator and its comparison with urokinase. Biochemistry 8: 79 1969;
- 15 Lange B. Kolorimetrische Analyse. Verlag Chemie GmbH, Weinheim 1952. 4th ed., p.452.
- 16 Lassen M. Heat denaturation of plasminogen in the fibrin plate method. Acta physiol. scand 27: 371 1953;
- 17 Lesuk A, Terminiello L, Traver J. H. Crystalline human urokinase: some properties. Science 747: 880 1965;
- 18 Lüscher E. F, Käser-Glanzmann R. A new method for quantitative determination of fibrinolytic activities, based on the use of fluorescent fibrin as a substrate. Vox Sang 6: 116 1961;
- 19 McCall D. C, Kline D. L. Mechanism of action and some properties of a tissue activator of plasminogen. Thrombos. Diathes. haemorrh. (Stuttg.) 14: 116 1965;
- 20 Nitschmann Hs, Schlunegger U. P, Schneider G. H. A method for the isolation of highly enriched human plasminogen from a residual globulin fraction. Vox Sang 7: 641 1962;
- 21 Ornstein L. Disc electrophoresis. I. Background and theory. Ann. N. Y. Acad. Sci 121: 321 1964;
- 22 Rickli E. E, Baunok I, Zaugg H, Nitschmann Hs. Solubilization of a tissue bound activator of plasminogen under physiological conditions. Chinio 21: 462 1967;
- 23 Rinderknecht H. A new technique for the fluorescent labelling of proteins. Experientia (Basel) 16: 430 1960;
- 24 Tagnon H. J, Pallade G. E. Activation of proplasmin by a factor from mammalian tissue. J. clin. Invest 29: 317 1950;
- 25 Taylor Jr. F. B, Botts J. Purification and characterization of streptokinase with studies of streptokinase activation of plasminogen. Biochemistry 7: 232 1968;
- 26 Warburg O, Christian W. Isolation and crystallization of enolase. Biochem. Z 310: 384 1942;
- 27 White W. F, Barlow G. H, Mozen M. M. The isolation and characterization of plasminogen activators (urokinase) from human urine. Biochemistry 5: 2160 1966;